|
TODAY'S HEADLINES
Pleasanton, CA—The Cooper Companies, Inc. announced it has entered into definitive agreements to acquire Sauflon Pharmaceuticals for approximately $1.2 billion. Sauflon forecasts revenue of approximately $210 million for its fiscal year ending October 31, 2014, up approximately 22 percent year-over-year. » More |
|
Philadelphia—If you didn't make it to the American Optometric Association's Optometry's Meeting last week in Philadelphia, we've got you covered. All of our meeting coverage is in one place. You can find the latest on age-related macular degeneration, AREDS2 controversies, new ophthalmic lenses, and making managed vision care plans work for your practice.» More |
|
San Diego, CA—Nicox Inc. is launching expanded access to Sequenom Laboratories' RetnaGene portfolio of genetic tests—RentaGene AMD and RetnaGene LR—which asses an individual's risk for advanced age-related macular degeneration (AMD). » More |
|
Fort Worth, TX—Alcon has released a compliance kit will help eyecare professionals educate their patients on how to take care of their contact lenses while also providing consumers with a clear doctor recommendation. » More |
|
Osaka, Japan—Santen Pharmaceutical recently announced that it has entered into an agreement with Merck & Co. to purchase Merck's ophthalmology products—Cosopt (dorzolamide/timolol), Cosopt PF, Trusopt (dorzolamide), Trusopt PF, Timoptic (timolol maleate ophthalmic solution), Timoptic PF, Timoptic XE (timolol maleate ophthalmic gel), Saflutan (tafluprost), and Taptiqom(tafluprost timolol)—in Japan, Europe, and Asia Pacific. » More |
|
CONNECT WITH Optometry Times
Join your colleagues in conversation, respond to hot-topic questions, and stay up to date on breaking news. Like and follow us today! |
 |
» Facebook |
 |
» Twitter |
|
Like
Tweet
